{
    "clinical_study": {
        "@rank": "136273", 
        "acronym": "SHEARWAVE", 
        "arm_group": {
            "arm_group_label": "Population", 
            "arm_group_type": "Experimental", 
            "description": "Two experimental interventions will be realized in each patient in this population : Shearwave (new diagnostic test of fibrosis) and Fibrotest .\nMoreover, liver biopsies, the gold standard for the fibrosis diagnosis is also realized in each patient within usual cares."
        }, 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine if  SWE and Fibrotest\u00ae/ Fibromax\u00ae, alone or\n      associated,  are effective methods to assess liver fibrosis in children."
        }, 
        "brief_title": "Non Invasive Assessment of Liver Fibrosis in Children: Comparison of ShearWave Elastography, Fibrotest and Liver Biopsy", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Liver Fibrosis", 
            "Children"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fibrosis", 
                "Liver Cirrhosis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Liver biopsy will be the gold standard to assess fibrosis using Ishak score and morphometric\n      evaluation of fibrosis. All children included will have a measure of liver stiffness using\n      SWE  with 5 measures performed in the area where the biopsy is performed and 5 measures in\n      an other place in  the liver.  Fibrotest\u00ae/ Fibromax\u00ae will be performed on blood sample. All\n      exams will be done within 1 month. diagnostic performance of SWE and Fibrotest\u00ae/ Fibromax\u00ae\n      will be assessed respectively. algorithm using the results of both technics will be tested\n      in order to test diagnostic performance and to obtain better performances."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age < 18 years;\n\n          -  indication to liver biopsy;\n\n          -  informed consent of both parents and child if applicable;\n\n          -  social insurance\n\n        Exclusion Criteria:\n\n        -"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "18 Years", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 20, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02041780", 
            "org_study_id": "P120128"
        }, 
        "intervention": {
            "arm_group_label": "Population", 
            "intervention_name": "Shearwave electrography", 
            "intervention_type": "Procedure"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Diagnostic", 
            "Liver fibrosis", 
            "Ishak score", 
            "Fibrotest", 
            "ShearWave elastography", 
            "Liver biopsies"
        ], 
        "lastchanged_date": "January 20, 2014", 
        "location": {
            "contact": {
                "email": "stephanie.franchi@bct.aphp.fr", 
                "last_name": "Stephanie FRANCHI-ABELA, MD", 
                "phone": "+33 (1) 45 21 31 21"
            }, 
            "facility": {
                "address": {
                    "city": "Le Kremlin-Bic\u00eatre", 
                    "country": "France", 
                    "zip": "94275"
                }, 
                "name": "AP-HP, Bic\u00eatre Hospital"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "France"
        }, 
        "number_of_arms": "1", 
        "official_title": "Non Invasive Assessment of Liver Fibrosis in Children: Evaluation of Diagnostic Performances of ShearWave Elastography (SWE) and Fibrotest\u00ae/ Fibromax\u00ae by Comparison With Fibrosis Score on Liver Biopsy", 
        "overall_contact": {
            "email": "stephanie.franchi@bct.aphp.fr", 
            "last_name": "St\u00e9phanie FRANCHI_ABELA, MD", 
            "phone": "+33 (1) 45 21 31 21"
        }, 
        "overall_official": {
            "affiliation": "AP-HP", 
            "last_name": "St\u00e9phanie FRANCHI-ABELA, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "France: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Histology is the gold standard to evaluate liver fibrosis", 
            "measure": "liver fibrosis evaluated by the ISHAK score and morphometric evaluation", 
            "safety_issue": "No", 
            "time_frame": "up to 1 month"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02041780"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "liver fibrosis evaluation : stiffness using SHEARWAVE elastography", 
                "safety_issue": "No", 
                "time_frame": "up 1 month"
            }, 
            {
                "measure": "Liver fibrosis evaluation using Fibrotest (Fibromax)", 
                "safety_issue": "No", 
                "time_frame": "up 1 month"
            }
        ], 
        "source": "Assistance Publique - H\u00f4pitaux de Paris", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Assistance Publique - H\u00f4pitaux de Paris", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "January 2014"
    }
}